Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
A hexahistidine-Zn 2+ -dye label reveals STIM1 surface exposure
2007 StandoutNobel
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Skin cancer in solid organ transplant recipients: Advances in therapy and management
2011
Risk‐adjusted relationship between voriconazole utilization and non‐melanoma skin cancer among lung and heart/lung transplant patients
2013
Voriconazole Prophylaxis in Lung Transplant Recipients
2006
Perioperative Antibiotics in Thoracic Surgery
2011
Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis
2013
Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients
2010
Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes
2007
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
Increased Mortality After Pulmonary Fungal Infection Within the First Year After Pediatric Lung Transplantation
2008
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program
2005
Pretransplant Aspergillus Colonization of Cystic Fibrosis Patients and the Incidence of Post–Lung Transplant Invasive Aspergillosis
2013
Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study
2005
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis
2008
Investigation of the Potential Relationships Between Plasma Voriconazole Concentrations and Visual Adverse Events or Liver Function Test Abnormalities
2006
Clinical impact of ganciclovir‐resistant cytomegalovirus infections in solid organ transplant patients
2005
Aspergillosis in Solid Organ Transplantation
2013
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis
2006
Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes
2010
Fungal infections in solid organ transplantation
2007
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Current Options in Antifungal Pharmacotherapy
2008
Variation in antifungal prophylaxis strategies in lung transplantation
2006
Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant
2013
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis
2012
Skin cancer in solid organ transplant recipients: Advances in therapy and management
2011
Nickel carcinogenesis
2003 Standout
HYPOGAMMAGLOBULINEMIA IN LUNG TRANSPLANT RECIPIENTS
2001
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
2008
Rapid diagnosis of invasive aspergillosis by antigen detection
2003
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole
2004
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
2007
Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
2010
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients
2005
Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant Recipients
2006
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
2016
Nickel essentiality, toxicity, and carcinogenicity
2002
High Incidence of Anticytomegalovirus Drug Resistance Among D+R− Kidney Transplant Recipients Receiving Preemptive Therapy
2011
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
2003
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
2006
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis
2004
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders
2007
Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness
2009
Anti‐Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
2009
Heavy metal pollution in the environment and their toxicological effects on humans
2020 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009
2009 Standout
Duration of Voriconazole Exposure: An Independent Risk Factor for Skin Cancer After Lung Transplantation
2012
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients
2010
Risk stratification for invasive aspergillosis in immunocompromised patients
2012
Infection in Solid-Organ Transplant Recipients
2007 Standout
Safety and Pharmacokinetics of Coadministered Voriconazole and Anidulafungin
2005
Valacyclovir for Cytomegalovirus Prophylaxis Reduces the Risk of Acute Renal Allograft Rejection
2005
Immunity to fungal infections
2011 Standout
The safety of interferon‐γ‐1b therapy for invasive fungal infections after hematopoietic stem cell transplantation
2005
Tie2-dependent VHL knockdown promotes airway microvascular regeneration and attenuates invasive growth of Aspergillus fumigatus
2013 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
2009
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
2012
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Use of High-Dose Ganciclovir for the Treatment of Cytomegalovirus Replication in Solid Organ Transplant Patients With Ganciclovir Resistance-Inducing Mutations
2013
Resistant cytomegalovirus in intestinal and multivisceral transplant recipients
2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
2014
Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole.
2011
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens
2013
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Is universal antifungal prophylaxis mandatory in lung transplant patients?
2013
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Review and Update
2003 Standout
Works of M. Haug being referenced
Enhanced cyclosporine–itraconazole interaction with cola in lung transplant recipients
2001
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir‐resistant cytomegalovirus infection
2002
The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants
2002
Determination of the trace elements zinc, copper, nickel and chromium in bone marrow and plasma of patients with non-Hodgkin lymphomas.
1993
Cytomegalovirus infection in seromismatched lung transplant recipients with and without prophylaxis with CMV immunoglobulin.
1996